COOL AMI EU Pivotal Trial to Assess Cooling as an Adjunctive Therapy to PCI In Patients With Acute MI (Phase A)
COOL-AMI EU Pivotal Trial: A Multicenter, Prospective, Randomized-Controlled Trial to Assess the Safety and Effectiveness of Cooling As an Adjunctive Therapy to Percutaneous Intervention in Patients With Acute Myocardial Infarction
Sponsor: ZOLL Circulation, Inc., USA
This NA trial investigates Acute Myocardial Infarction and is currently completed. ZOLL Circulation, Inc., USA leads this study, which shows 11 recorded versions since 2017 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Dec 2021 — Jul 2024 [monthly]
Completed NA
-
Mar 2021 — Dec 2021 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Jan 2021 — Mar 2021 [monthly]
Unknown Status NA
▶ Show 6 earlier versions
-
Jul 2020 — Jan 2021 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Nov 2018 — Jul 2020 [monthly]
Recruiting NA
Status: Enrolling By Invitation → Recruiting
-
Jul 2018 — Nov 2018 [monthly]
Enrolling By Invitation NA
-
Jun 2018 — Jul 2018 [monthly]
Enrolling By Invitation NA
-
Jul 2017 — Jun 2018 [monthly]
Enrolling By Invitation NA
-
Jun 2017 — Jul 2017 [monthly]
Enrolling By Invitation NA
First recorded
Apr 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- ZOLL Circulation, Inc., USA
For direct contact, visit the study record on ClinicalTrials.gov .